Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$4.80 USD

4.80
1,810

0.00 (0.00%)

Updated Jun 18, 2026 03:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (152 out of 247)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Allscripts Launches Clinical Pathways for Cancer Treatment

by Zacks Equity Research

Allscripts Healthcare Solutions, Inc. (MDRX) recently announced the launch of Clinical Pathways program for the treatment of cancer.

    Zacks Equity Research

    Allscripts (MDRX) Q4 Earnings Miss Estimates, View Upbeat

    by Zacks Equity Research

    Allscripts Healthcare Solutions, Inc.(MDRX) reported fourth-quarter 2016 earnings of 10 cents per share, which missed the Zacks Consensus Estimate by 2 cents.

      Zacks Equity Research

      MedTech Stocks' Q4 Earnings on Feb 16: LH, WST and MDRX

      by Zacks Equity Research

      Let's take a look at the major MedTech stocks slated to release their fourth-quarter 2016 numbers on Feb 16.

        Zacks Equity Research

        American International Group (AIG): Q4 Earnings Preview

        by Zacks Equity Research

        We expect American International Group, Inc. (AIG) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 14.

          Zacks Equity Research

          Can Allscripts (MDRX) Surprise Investors in Q4 Earnings?

          by Zacks Equity Research

          Allscripts Healthcare Solutions Inc. (MDRX) is scheduled to release fourth-quarter 2016 results on Feb 16.

            Zacks Equity Research

            4 Healthcare Players Likey to Trump Q4 Earnings Estimates

            by Zacks Equity Research

            Trump's victory has sent waves across the Healthcare industry.

              Zacks Equity Research

              Allscripts Buys Core Medical Solutions, Expands in Australia

              by Zacks Equity Research

              Allscripts Healthcare Solutions, Inc. (MDRX), a leading global provider of information technology and services to healthcare organizations, recently announced the acquisition of Core Medical Solutions to expand its offerings in Australia.

                Zacks Equity Research

                Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels

                by Zacks Equity Research

                Allscripts Healthcare Solutions Inc. (MDRX) recently provided a bullish update on bookings alongside providing a number of financial updates on fourth quarter 2016.